Archive: 04/06/2018

Genetic testing for statin therapy not cost-effective

Current United States Preventive Service Task Force (USPSTF) guidelines call for screening all Americans between the ages of 40 and 75 years to determine eligibility for statins, a class of cholesterol-lowering medications. ...

page 9 from 11